Email this page To: From: Subject: Message: Ruxolitinib - Ruxolitinib, also called Jakafi®, is an anti-cancer medicine. Ruxolitinib is taken by mouth. Learn more about dosing, side effects and safety - https://www.stjude.org/treatment/patient-resources/caregiver-resources/medicines/a-z-list-of-medicines/ruxolitinib.html A summary of this page will be sent along with your message I am a referring physician Yes, I would like to receive email updates. Send Email Your message has been emailed successfully. Thank you for your interest in St. Jude Children's Research Hospital.